© 2020 MJH Life Sciences and Formulary Watch. All rights reserved.
June 30, 2020
Price of the drug to treat hospitalized patients revealed.
By Christine Blank
June 15, 2020
The unique formulation is a dispersible tablet for children.
June 08, 2020
Five pharma markers are recalling the diabetes medication due to the presence of a carcinogenic ingredient.
HHS says supply could run out by the end of this month.
June 05, 2020
The agency welcomes another option for serious bacterial infections.
June 02, 2020
Brilinta is already approved to prevent atherothrombotic events in ASC.
Immediately after the FDA said it found elevated levels of the carcinogenic ingredient N-nitrosodimethylamine (NDMA) in certain extended release (ER) metformin products, the first 2 major recalls are underway.
May 28, 2020
IV artesunate is the only drug available in the U.S. to treat the disease.
May 19, 2020
FDA authorizes first stand-alone, at-home test, plus other top COVID-19 news stories.
May 11, 2020
Antigen tests, a new category, have a major advantage and disadvantage over COVID-19 tests already approved.